Results 151 to 160 of about 4,769,368 (347)
Influence of Treatment Factors on the Outcome after Hip Fractures
, 1989 Thomas Dolk, Thomas Dolk
openalex +2 more sources
Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer [PDF]
, 1994 Judith D. Sears +3 more
openalex +1 more source
Molecular Oncology, EarlyView.Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu +11 more
wiley +1 more source
Outcome after acute traumatic subdural and epidural hematomas in patient admitted in Fatemi hospital,Ardabil,Iran between: 1381-1385 [PDF]
Introduction : The most common caused of mortality in individuals with head trauma, are epidural and subural hematomas. In the last three decades regarding improvements in saving patients, lives and post — op monitoring and intensive care, the ...
اسکندراوغلی, بهزاد +2 more
core
Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer
, 1988 Margaret Kemeny +2 more
openalex +1 more source
Molecular Oncology, EarlyView.This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani +14 more
wiley +1 more source
Endometrial biopsy during treatment of luteal phase defects is predictive of therapeutic outcome
, 1983 Douglas C. Daly +3 more
openalex +1 more source
Acute liver failure: improving outcome despite a paucity of treatment options [PDF]
, 1993 David Mutimer, James Neuberger
openalex +1 more source
Molecular Oncology, EarlyView.B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez +17 more
wiley +1 more source
Clinicopathologic features and treatment outcome of children with large- cell lymphoma and the t(2;5)(p23;q35) [PDF]
, 1994 J T Sandlund +9 more
openalex +1 more source